Spot Trading’s SELLAS Life Sciences SLS Stock Holding History

Spot Trading’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-3	Closed	-$3K	–	3350
2017 Q2	$3K	Hold	3	–	–	﹤0.01%	3114
2017 Q1	$3K	Buy	+3	New	+$4.97K	﹤0.01%	2826
2016 Q4	–	Hold	0	–	–	–	3133

Other funds holding SLS

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Spot Trading's SLS Position: Q3 2017 in Review

Spot Trading sold out of SELLAS Life Sciences (SLS) in Q3 2017, closing a stake of 3 shares — an estimated $3K sold.

Spot Trading first reported a position in SLS in Q1 2017 and held it in 2 quarters. The position peaked at $3K in Q2 2017. 28 funds tracked by Wall St. Rank hold SLS as of Q3 2017.

Spot Trading reported no remaining SELLAS Life Sciences position as of Q3 2017 after selling out during the quarter.
Spot Trading sold 3 SELLAS Life Sciences shares in Q3 2017, an estimated $3K.
Spot Trading first reported a position in SELLAS Life Sciences in Q1 2017 and held it in 2 quarters.
Spot Trading's SELLAS Life Sciences position peaked at $3K in Q2 2017.
28 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.